NFKB1 and diffuse large B-cell lymphoma: Consumption of glucose and glutamine or treatment with an HBP inhibitor (azaserine) in DLBCL cells can reduce the O-GlcNAc substrates and inhibit the activation of NF-κB, further inducing G0/G1 cell arrest and apoptosis [43] (Figure 2, Table 3).